Merit Medical Systems Inc (MMSI) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Merit Medical Systems Inc  (NASDAQ: MMSI)
 

Merit Medical Systems Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Merit Medical Systems Inc's inventory turnover ratio sequentially decreased to 2.37 in the first quarter 2026, unsurprisingly, as the Merit Medical Systems Inc markets continue to deteriorate, and MMSI's faces growing challenges to bring down its inventories. Merit Medical Systems Inc's average inventory processing period in the Mar 31 2026 quarter, has increased to 154 days, from 153 days, in the Dec 31 2025 quarter.

Within Healthcare sector 162 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1019 in the fourth quarter 2025, to 1383.

MMSI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Merit Medical Systems Inc Market Share?

What is Inventory Turnover Ratio?




MMSI Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 10.84 % 9.03 % 5.16 % 8.41 % 5.02 %
Y / Y Cost of Sales Growth 7.65 % 8.7 % 8.24 % 11.93 % 7.02 %
Inventory Turnover Ratio (TTM) 2.37 2.39 2.39 2.37 2.35
MMSI's Total Ranking # 1383 # 1019 # 888 # 1228 # 1050
Average inventory processing period 154 153 153 154 155
Seq. Inventory Growth 5.6 % 2.19 % 1 % 1.69 % 3.88 %
Seq. Cost of Sales Growth -1.5 % 1.52 % 0 % 7.65 % -0.54 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 65
Healthcare Sector # 163
Overall Market # 1383

Inventory Turnover Ratio Statistics
High Average Low
3.37 2.75 2.14
(Dec 31 2018)   (Sep 30 2012)




Financial Statements
Merit Medical Systems Inc's Inventories $ 352 Millions Visit MMSI's Balance sheet
Merit Medical Systems Inc's Cost of Revenues TTM $ 791 Millions Visit MMSI's Income Statement
What are MMSI's Sales? Visit MMSI's Sales by Segment

Other Inventory Turnover Ratios
Merit Medical Systems Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MMSI's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MMSI's Competitors
Inventory Turnover Ratio for MMSI's Suppliers
Inventory Turnover Ratio for MMSI's Customers

You may also want to know
MMSI's Sales Growth Rates MMSI's Pe Price to earnings ratio MMSI's Receivables Turnover Ratio MMSI's Stock Quote
MMSI's Net Income Growth Rates MMSI's Ps Price to Sales ratio MMSI's Sales per Employee MMSI's Asset Turnover Ratio
MMSI's Net Margin MMSI's Pb Price to Book ratio MMSI's Financial Strength Ratios MMSI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions

Date modified: 2026-08-30T14:50:23+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.